相关实验视频

Updated: Jul 15, 2025

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

在现场治疗黑色素瘤的局部和内部免疫疗法:一篇评论

Sandra Martínez-Fernández^1,2, Beatriz González-Sixto^1,2, Martina Espasandín-Arias^1,2

¹Department of Dermatology, Pontevedra University Hospital, 36001 Pontevedra, Spain.

|September 28, 2023

概括

局部免疫疗法,特别是伊米基莫德,为现场黑色素瘤 (MIS) 提供了可靠的治疗选择,特别是当手术不理想时. 它显示了令人鼓舞的清除和复发率,并可以减少手术缺陷的大小.

科学领域:

皮肤病学皮肤病学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

现场黑色素瘤 (MIS) 发病率正在上升,这给治疗带来了挑战.
手术切除是标准的,但通常不适合老年患者或化品敏感区域.
非手术选择对于在特定患者群体中管理MIS至关重要.

研究的目的:

审查免疫治疗在治疗黑色素瘤中的应用.
评估免疫疗法作为单一疗法和与其他治疗结合使用.
评估不同免疫治疗剂对MIS的疗效.

主要方法:

对MIS免疫疗法研究的文献综述.
对伊米基莫德,内伤性干扰素α和 ingenol mebutate 的临床数据的分析.
对治疗结果的评估,包括清除和复发率.

主要成果:

伊米基莫德在MIS治疗中表现出令人鼓舞的现实世界结果.
清除和复发率是有利的,用伊米基莫德单一治疗或作为辅助治疗.
新辅助性伊米基莫德治疗可以减少所需的外科手术缺陷大小.

结论:

局部免疫疗法,特别是伊米基莫德,对于某些MIS病例来说是一个有价值的治疗替代方案.
免疫疗法在临床实践中经常使用,并为某些患者提供了很好的结果.
进一步的研究可能会扩大免疫治疗在MIS治疗中的作用.

关键词:

免疫疗法免疫疗法这是一个内部破裂.林氏病恶性恶性黑色素瘤在位的情况审查审查审查审查审查审查专题局部局部局部局部

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.